Finance

Beta
Lists
SER:NYSEAMERICAN
Serina Therapeutics Inc
$1.77
-6.84%
(-0.13) 1D
$1.78
+0.56% (+0.0100)
After hours
Closed: Jun 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SER...
Open
$1.90
High
$1.95
Low
$1.73
Mkt. cap
26.55M
Avg. vol.
78.93K
Volume
0.00
52-wk high
$7.92
52-wk low
$1.22
EPS
-$1.98
Beta
1.17
Shares outstanding
15.00M
No. of employees
16
Open
$1.90
High
$1.95
Low
$1.73
Mkt. cap
26.55M
Avg. vol.
78.93K
Volume
0.00
52-wk high
$7.92
52-wk low
$1.22
EPS
-$1.98
Beta
1.17
Shares outstanding
15.00M
No. of employees
16
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to SER in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for SER in the last 3 months.
Highest
Current $1.77
$11.00 (+521.47%)
Average
$11.00 (+521.47%)
Lowest
$11.00 (+521.47%)
News stories
From sources across the web
About Serina Therapeutics Inc
CEO-
Employees16
Founded2006
HeadquartersHuntsville, Alabama, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
130.00K
-
-
-
Cost of goods sold
3.15M
3.65M
3.40M
3.20M
Cost of revenue
3.15M
3.65M
3.40M
3.20M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.54M
2.74M
2.81M
3.08M
Operating expense
2.54M
2.74M
2.81M
3.08M
Total operating expenses
5.70M
6.39M
6.21M
6.28M
Operating income
-5.56M
-6.39M
-6.21M
-6.28M
Other non operating income
-888.00K
1.80M
3.09M
1.19M
EBT including unusual items
-6.46M
-4.60M
-3.32M
-6.89M
EBT excluding unusual items
-6.46M
-4.60M
-3.32M
-5.28M
Income tax expense
-
-
18.00K
7.00K
Effective tax rate
-
-
-0.54%
-0.10%
Other operating expenses
-
-
-
-
Net income
-6.45M
-4.58M
-3.34M
-6.90M
Net profit margin
-4,960.00%
-
-
-
Earnings per share
-0.66
-0.51
-0.31
-0.53
Interest and investment income
-
-
-
-
Interest expense
-9.00K
-6.00K
-198.00K
-189.00K
Net interest expenses
-9.00K
-6.00K
-198.00K
-189.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.55M
-6.38M
-6.18M
-6.26M
Gain or loss from assets sale
-
-
257.00K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more